Is Sun wooing Lizhu for a larger presence in China?
This article was originally published in Scrip
Executive Summary
Even as Sun Pharmaceutical Industries assimilates Takeda-owned URL's generic business (scripintelligence.com, 18 December 2012), there is speculation that the Indian firm may also be keen to build up its branded generics business in China, possibly via an alliance or even a partial acquisition.